Green Tea Hp

A Catechin-rich Beverage Improves Obesity and Blood Glucose Control in Patients with Type 2 Diabetes. Tomonori et al. Obesity (2008) 17, 310–317.

We investigated the effects of continuous ingestion of a catechin-rich beverage in patients with type 2 diabetes who were not receiving insulin (Ins) therapy in a double-blind controlled study. The participants ingested green tea containing either 582.8 mg of catechins (catechin group; n = 23) or 96.3 mg of catechins (control group; n = 20) per day for 12 weeks. At week 12, the decrease in waist circumference was significantly greater in the catechin group than in the control group. Adiponectin, which is negatively correlated with visceral adiposity, increased significantly only in the catechin group. Although the increase in Ins at week 12 was significantly greater in the catechin group than in the control group, no apparent difference was noted between the two groups in glucose and hemoglobin A1c. In patients treated with insulinotropic agents, the increase in Ins at week 12 was significantly greater in the catechin group than in the control group. This significant increase in Ins levels was observed only in the catechin group. In the catechin group receiving other treatments, Ins levels remained unchanged. In addition, in patients treated with insulinotropic agents, the decrease in hemoglobin A1c at week 12 was significantly greater in the catechin group than in the control group. These results suggest that a catechin-rich beverage might have several therapeutic uses: in the prevention of obesity; in the recovery of Ins-secretory ability; and, as a way to maintain low hemoglobin A1c levels in type 2 diabetic patients who do not yet require Ins therapy.

“The accumulation of thirty minutes of daily activity in addition to making healthy dietary choices can result in slow but steady changes in general wellness. For those who are type II diabetic or at risk of type II diabetes, adding more than 400 mg of EGCG per day can have a therapeutic affect! The changes noted from this study suggest a significant difference in insulin needs for at risk and current diabetics. Simple consistent changes lead to great differences over time.” – Josh Smith

A Catechin-rich Beverage Improves Obesity and Blood Glucose Control in Patients with Type 2 Diabetes. Tomonori et al. Obesity (2008) 17, 310–317.

We investigated the effects of continuous ingestion of a catechin-rich beverage in patients with type 2 diabetes who were not receiving insulin (Ins) therapy in a double-blind controlled study. The participants ingested green tea containing either 582.8 mg of catechins (catechin group; n = 23) or 96.3 mg of catechins (control group; n = 20) per day for 12 weeks. At week 12, the decrease in waist circumference was significantly greater in the catechin group than in the control group. Adiponectin, which is negatively correlated with visceral adiposity, increased significantly only in the catechin group. Although the increase in Ins at week 12 was significantly greater in the catechin group than in the control group, no apparent difference was noted between the two groups in glucose and hemoglobin A1c. In patients treated with insulinotropic agents, the increase in Ins at week 12 was significantly greater in the catechin group than in the control group. This significant increase in Ins levels was observed only in the catechin group. In the catechin group receiving other treatments, Ins levels remained unchanged. In addition, in patients treated with insulinotropic agents, the decrease in hemoglobin A1c at week 12 was significantly greater in the catechin group than in the control group. These results suggest that a catechin-rich beverage might have several therapeutic uses: in the prevention of obesity; in the recovery of Ins-secretory ability; and, as a way to maintain low hemoglobin A1c levels in type 2 diabetic patients who do not yet require Ins therapy.

“The accumulation of thirty minutes of daily activity in addition to making healthy dietary choices can result in slow but steady changes in general wellness. For those who are type II diabetic or at risk of type II diabetes, adding more than 400 mg of EGCG per day can have a therapeutic affect! The changes noted from this study suggest a significant difference in insulin needs for at risk and current diabetics. Simple consistent changes lead to great differences over time.” – Josh Smith